Home  >  Products  >  SNF8 (SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)) Blocking Peptide (the middle region of SNF8)(100ug)
SNF8 (SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)) Blocking Peptide (the middle region of SNF8)(100ug)

SNF8 (SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)) Blocking Peptide (the middle region of SNF8)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SNF8 Antibody(ARP57950_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57950
Size: 100ug
Weight: 29kDa
Gene: 11267
Format: Lyophilized powder
Target: ELL encodes an RNA polymerase II transcription factor that undergoes frequent translocation in acute myeloid leukemia (AML). In addition to its elongation activity, ELL contains a novel type of RNA polymerase II interaction domain that is capable of repressing polymerase activity in promoter-specific transcription. EAP30 is a subunit of the ELL complex. EAP30 can interact with ELL and derepress ELL's inhibitory activity in vitro.SNF8, VPS25 (MIM 610907), and VPS36 (MIM 610903) form ESCRT-II (endosomal sorting complex required for transport II), a complex involved in endocytosis of ubiquitinated membrane proteins. SNF8, VPS25, and VPS36 are also associated in a multiprotein complex with RNA polymerase II elongation factor.
Alternative names: Dot3; EAP30; VPS22
See Full Product Listings >